Akums Drugs and Pharmaceuticals Gets CDSCO Panel Nod To study Norethindrone, Estradiol, Relugolix FDC Dr. Divya Colin30 July 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to the drug...
FDA approves first oral dissolvable contraceptive pill Dr. Kamal Kant Kohli26 July 2024 8:30 PM ISTThe US Food and Drug Administration has approved a mouth dissolving hormonal birth control pill for people who have trouble swallowing.The approval...
Sun Pharmaceutical Industries Gets CDSCO Panel Nod to Study FDC of Relugolix, Estradiol, Norethindrone Acetate Dr. Divya Colin8 April 2024 6:00 PM ISTNew Delhi: Rejecting for clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
No safety data available, Conduct Phase-III CT: CDSCO Panel Tells Akums on Norethindrone, Estradiol, Relugolix film-coated tablet Dr. Divya Colin12 Jan 2024 6:00 PM ISTNew Delhi: Citing that there is no safety and efficacy data, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Conduct Phase III CT: CDSCO Panel Tells Sun Pharma on FDC Relugolix plus Estradiol plus Norethindrone Acetate Tablets Dr. Divya Colin10 Jan 2024 6:00 PM ISTNew Delhi: Citing that there is no safety and efficacy data on Indian population, the Subject Expert Committee (SEC) functional under the Central Drug...
Pfizer, Myovant Sciences get USFDA nod for MYFEMBREE Ruchika Sharma7 Aug 2022 11:30 AM ISTMYFEMBREE offers an effective, once-daily treatment option for the management of moderate to severe pain associated with endometriosis, with a...
Relugolix combo significantly reduces menstrual bleeding in uterine fibroids patients: NEJM Medha Baranwal18 Feb 2021 7:01 PM ISTUSA: Once-daily treatment with relugolix combination therapy (relugolix, estradiol and norethindrone acetate) significantly reduces menstrual bleeding...
Lupin recalls birth control pill Mibelas 24 Fe in US over failed impurities specification Ruchika Sharma22 Aug 2020 1:00 PM ISTThe reason for the recall is" failed impurities/degradation specifications: Out of specification result observed in related substance test", the USFDA...
